Release of [3H]acetylcholine in human isolated bronchi. Effect of indomethacin on muscarinic autoinhibition. 1995

I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
Department of Pharmacology, University of Mainz, Germany.

Receptor-mediated regulation of acetylcholine release in the airways, particularly in humans, remains unclear. In the present study, the tissue content of acetylcholine and release of [3H]acetylcholine were measured in freshly dissected human bronchi obtained at thoracotomy. Large (main and lobar bronchi) and small (segmental and subsegmental bronchi) airways contained considerable amounts of endogenous acetylcholine (300 +/- 50 pmol/100 mg wet weight), whereas significantly less was found in lung parenchyma (60 +/- 30 pmol/100 mg). Isolated small bronchi incubated in an organ bath with the precursor [3H]choline synthesized significant amounts of [3H]acetylcholine (26,000 +/- 4,000 dpm/100 mg). Subsequent transmural stimulation (four 20 s trains at 15 Hz) of radiolabeled bronchi caused an enhanced tritium outflow that was abolished by removal of extracellular calcium or by tetrodotoxin. HPLC analysis of the medium collected before, during, and after transmural stimulation showed that the electrically stimulated tritium outflow represented exclusively [3H]acetylcholine, whereas the outflow of [3H]choline and [3H]phosphorylcholine was not affected by electrical stimulation. Oxotremorine (0.1 and 1 mumol/L) inhibited evoked [3H]acetylcholine release in a concentration-related manner, whereas atropine (0.03 mumol/L) enhanced evoked [3H]acetylcholine release. Inactivation of cyclooxygenase activity by 3 mumol/L of indomethacin did not impair the inhibitory effect of 0.1 or 1 mumol/L of oxotremorine. In conclusion, the present experiments indicate a considerable cholinergic innervation of human large and small airways.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D001285 Atropine An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. AtroPen,Atropin Augenöl,Atropine Sulfate,Atropine Sulfate Anhydrous,Atropinol,Anhydrous, Atropine Sulfate,Augenöl, Atropin,Sulfate Anhydrous, Atropine,Sulfate, Atropine
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
August 1997, American journal of respiratory and critical care medicine,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
March 1987, Pharmacology & toxicology,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
September 1998, British journal of pharmacology,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
February 1990, Neuropharmacology,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
May 2007, Life sciences,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
April 1990, Naunyn-Schmiedeberg's archives of pharmacology,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
November 1997, The Journal of pharmacology and experimental therapeutics,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
August 1982, Acta physiologica Scandinavica,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
August 1998, Japanese journal of pharmacology,
I Wessler, and H Bender, and P Härle, and K D Höhle, and G Kirdorf, and H Klapproth, and T Reinheimer, and J Rícný, and K E Schniepp-Mendelssohn, and K Racké
January 1988, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!